glp-1 alzheimer's study Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science Disappointing GLP-1 Results in Alzheimer's

I had stage 3 renal cell carcinoma

Its an argument for fighting for better insurance coverage and pricing, not for psychiatrists avoiding prescribing them

Slow titration helps

Consistent with greater food consumption, the percent abundance of fecal butyrate levels, primarily produced by gut bacteria 62 , was significantly greater in cold-stressed male mice, independent of genotype (Fig

Nat Rev Cardiol 21(2):69 [DOI] [PubMed] [Google Scholar] 80.Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J et al (2025) Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

The investigators reported significant improvements in HbA1c versus placebo with adjuvant liraglutide [39]